Parkitidin ER 193 Tablet contains Amantadine, a medicine classified as a Dopamine agonist and Anti-viral agent. It is primarily used to manage Parkinson’s disease, a degenerative nervous condition characterized by tremors, muscle stiffness, and slow movements. Additionally, it is effective in preventing and treating various strains of influenza A virus, which is caused by the replication of the virus within the body.

Moreover, PARKITIDIN ER 193 is prescribed to alleviate the symptoms of shingles, a painful condition resulting from the reactivation of the chickenpox virus, and drug-induced extrapyramidal reactions induced by medications like antipsychotics. Before initiating treatment with PARKITIDIN ER 193, it is vital to disclose any existing kidney, liver, or heart conditions, as well as any history of mental illnesses like schizophrenia or dementia, and glaucoma.

It is emphasized that PARKITIDIN ER 193 should not be consumed during pregnancy or while breastfeeding. Furthermore, it is not recommended for use in newborns or infants below the age of 1 year, and caution should be exercised when administering it to elderly patients aged 65 years or older. It is advisable to seek medical advice before commencing a regimen with this medication.

Potential side effects of PARKITIDIN ER 193 may include loss of appetite, fatigue, dry mouth, constipation, nausea, or vomiting. Should any of these side effects persist or worsen, consulting a healthcare provider is essential to ensure proper management.